Skip to main content
. Author manuscript; available in PMC: 2024 Mar 15.
Published in final edited form as: Biol Psychiatry. 2022 Aug 18;93(6):536–545. doi: 10.1016/j.biopsych.2022.08.010

Figure 1.

Figure 1.

Comorbidity among substance use disorders in the Yale-Penn dataset. Venn diagrams show the comorbidity among DSM-IV substance dependence diagnoses (top) and DSM-5 use disorder diagnoses (bottom) in African (AFR) individuals (left) and European (EUR) individuals (right). Number and percentage of individuals with overlapping disorders is labeled in each section.